Correlation Between Neuropace and BrainsWay
Can any of the company-specific risk be diversified away by investing in both Neuropace and BrainsWay at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and BrainsWay into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and BrainsWay, you can compare the effects of market volatilities on Neuropace and BrainsWay and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of BrainsWay. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and BrainsWay.
Diversification Opportunities for Neuropace and BrainsWay
Significant diversification
The 3 months correlation between Neuropace and BrainsWay is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and BrainsWay in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BrainsWay and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with BrainsWay. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BrainsWay has no effect on the direction of Neuropace i.e., Neuropace and BrainsWay go up and down completely randomly.
Pair Corralation between Neuropace and BrainsWay
Given the investment horizon of 90 days Neuropace is expected to generate 1.05 times more return on investment than BrainsWay. However, Neuropace is 1.05 times more volatile than BrainsWay. It trades about 0.1 of its potential returns per unit of risk. BrainsWay is currently generating about 0.06 per unit of risk. If you would invest 646.00 in Neuropace on September 1, 2024 and sell it today you would earn a total of 414.00 from holding Neuropace or generate 64.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neuropace vs. BrainsWay
Performance |
| Timeline |
| Neuropace |
| BrainsWay |
Neuropace and BrainsWay Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neuropace and BrainsWay
The main advantage of trading using opposite Neuropace and BrainsWay positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, BrainsWay can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BrainsWay will offset losses from the drop in BrainsWay's long position.| Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
| BrainsWay vs. Brainsway | BrainsWay vs. Bluejay Diagnostics | BrainsWay vs. Venus Concept | BrainsWay vs. Icecure Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |